Disparities between Uptake of Germline BRCA1 / 2 Gene Tests and Implementation of Post-test Management Strategies in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

CONCLUSION: Although BRCA1/2 gene tests have been substantially expanded, the uptake of post-test risk management strategies, including breast cancer screening for BRCA1/2-mutated patients and cascade testing for family members, has remained low. Strategies to increase its uptake and education about the importance of post-test risk managements are needed.PMID:34609091 | PMC:PMC8490789 | DOI:10.3346/jkms.2021.36.e241
Source: Journal of Korean Medical Science - Category: Biomedical Science Authors: Source Type: research

Related Links:

More News: Academia | Biomedical Science | Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Education | Epithelial Cancer | Fallopian Tube Cancer | Genetics | Mammography | Ovarian Cancer | Ovaries | Peritoneal Cancer | Science | Study | Universities & Medical Training | Women